| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010360 |
| Receipt No. | R000012118 |
| Official scientific title of the study | Influence of polymorphisms of adenosine A2 receptor and dopamine D2 receptor on mental calculations, blood pressure and pulse rate after intake of caffeine: a double-blind randomized placebo-controlled clinical trial. |
| Date of disclosure of the study information | 2013/04/01 |
| Last modified on | 2017/09/19 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Influence of polymorphisms of adenosine A2 receptor and dopamine D2 receptor on mental calculations, blood pressure and pulse rate after intake of caffeine: a double-blind randomized placebo-controlled clinical trial. | |
| Title of the study (Brief title) | Influence of polymorphisms of adenosine A2 receptor and dopamine D2 receptor on the effect of caffeine | |
| Region |
|
|
| Condition | |||
| Condition | Effect of caffeine | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | To reveal the influence of polymorphisms of adenosine A2 receptor and dopamine D2 receptor on effect of caffeine 200 mg on mental calculation ability, blood pressure and pulse rate. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Change of the accurate number of mental calculation after intake caffeine 200 mg compared to decafe |
| Key secondary outcomes | Change of blood pressure and pulse rate after intake caffeine 200 mg compared to decafe |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | intake coffee 150 mL with caffeine 200mg | |
| Interventions/Control_2 | intake coffee 150 mL without caffeine | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy adult volunteers | |||
| Key exclusion criteria | 1. cardiovascular disease that should be treated
2. severe liver disease 3. severe renal disease 4. pregnant women and women suspected of being pregnant 5. severe allergic reaction and allergic reaction to caffeine 6. gastric ulcer 7. glaucoma 8. On medical treatment 9. Not appropriate to this study by other reasons |
|||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Toshiyuki Sasaguri |
| Organization | Faculty of Medical Science, Kyushu University |
| Division name | Department of Clinical Pharmacology |
| Address | 3-1-1 Maidashi Higashi-ku Fukuoka |
| TEL | +81-92-642-6082 |
| sasaguri@clipharm.med.kyushu-u.ac.jp | |
| Public contact | |
| Name of contact person | Tatsuya Yoshihara |
| Organization | Faculty of Medical Sciences, Kyushu University |
| Division name | Department of Clinical Pharmacology |
| Address | 3-1-1 Maidashi Higashi-ku Fukuoka |
| TEL | +81-92-642-6082 |
| Homepage URL | |
| tatsuya@clipharm.med.kyushu-u.ac.jp | |
| Sponsor | |
| Institute | Department of Clinical Pharmacology, Faculty of Medical Science, Kyushu University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012118 |